Pivot Bio Analysis: $2.0B Raised

Microbial nitrogen solutions for sustainable agriculture

Deliver nitrogen directly to corn roots for improved yield; Enhance wheat productivity with consistent nitrogen supply; Provide nitrogen for small grains like barley and oats; Increase corn silage tonnage and nutrient levels; Reward farmers for sustainable nitrogen practices through N-OVATOR®

Pivot Bio primarily focuses on the agricultural market, specifically targeting crop production through innovative microbial nitrogen solutions. Their products are designed to optimize nitrogen delivery directly to plant roots, thereby enhancing crop yields and sustainability. They aim to transform agriculture by reducing reliance on synthetic fertilizers and improving nitrogen efficiency in farming practices.

Recognized in TIME magazine's 200 Best Inventions; Over $6 million paid to farmers through N-OVATOR® since 2022; Achieved 1,050,000 metric tons of CO2e avoided since 2022

Pivot Bio recently closed a $430 million Series D funding round on August 29, 2023. The funding was led by DCVC and Temasek, among other investors.

Pivot Bio's products have received regulatory approvals from the USDA, FDA, and EPA in the United States. They are approved for distribution and use in 47 U.S. states, excluding Alaska, California, and Hawaii. The company emphasizes that their products are regulated in every country where they operate.